Abstract
The following article will focus on the role of diffusion-weighted MRI for the assessment of response to neoadjuvant combined chemoradiation therapy in rectal cancer patients. The interest of diffusion-weighted imaging for tumor characterization will be discussed, as well as the evaluation of clearance from the mesorectal fascia, nodal downstaging, assessment of complete response and the prediction of response before and during combined chemoradiation therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
